Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Times Interest Earned (2016 - 2017)

Corcept Therapeutics' Times Interest Earned history spans 2 years, with the latest figure at $130.56 for Q2 2017.

  • For Q2 2017, Times Interest Earned rose 4497.35% year-over-year to $130.56; the TTM value through Mar 2018 reached $705.2, up 857.41%, while the annual FY2011 figure was -$1293.3, 17.84% down from the prior year.
  • Times Interest Earned for Q2 2017 was $130.56 at Corcept Therapeutics, up from $2.84 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $130.56 in Q2 2017 and bottomed at $2.84 in Q2 2016.